These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29204064)

  • 21. Can we better protect patients with inflammatory bowel disease against infections - patient attitude and personal immunization knowledge.
    Waszczuk K; Waszczuk E; Szenborn L
    Acta Gastroenterol Belg; 2018; 81(2):257-261. PubMed ID: 30024696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.
    Matsumoto H; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
    J Gastroenterol; 2015 Aug; 50(8):876-86. PubMed ID: 25672513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.
    Marín AC; Gisbert JP; Chaparro M
    World J Gastroenterol; 2015 Oct; 21(40):11273-81. PubMed ID: 26527572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy.
    Lu Y; Bousvaros A
    J Pediatr Gastroenterol Nutr; 2010 May; 50(5):562-5. PubMed ID: 20639716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 'cocoon immunization strategy' among patients with inflammatory bowel disease.
    Waszczuk K; Waszczuk E; Mulak A; Szenborn L; Paradowski L
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):249-53. PubMed ID: 25569568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine.
    Lee CK; Kim HS; Ye BD; Lee KM; Kim YS; Rhee SY; Kim HJ; Yang SK; Moon W; Koo JS; Lee SH; Seo GS; Park SJ; Choi CH; Jung SA; Hong SN; Im JP; Kim ES;
    J Crohns Colitis; 2014 May; 8(5):384-91. PubMed ID: 24144611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents.
    Eickstaedt JB; Killpack L; Tung J; Davis D; Hand JL; Tollefson MM
    Pediatr Dermatol; 2017 May; 34(3):253-260. PubMed ID: 28211161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy.
    Lu Y; Bousvaros A
    Gastroenterol Hepatol (N Y); 2014 Jun; 10(6):355-63. PubMed ID: 25013388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.
    Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunizations in Pediatric and Adult Patients with Inflammatory Bowel Disease: A Practical Case-based Approach.
    Long MD; Gulati A; Wohl D; Herfarth H
    Inflamm Bowel Dis; 2015 Aug; 21(8):1993-2003. PubMed ID: 25966839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How do we manage vaccinations in patients with inflammatory bowel disease?
    Esteve Comas M; Loras Alastruey C; Fernandez-Bañares F
    Dig Dis; 2009; 27(3):370-4. PubMed ID: 19786767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
    Karmiris K; Bossuyt P; Sorrentino D; Moreels T; Scarcelli A; Legido J; Dotan I; Naismith GD; Jussila A; Preiss JC; Kruis W; Li AC; Bouguen G; Yanai H; Steinwurz F; Katsanos KH; Subramaniam K; Tarabar D; Zaganas IV; Ben-Horin S;
    J Crohns Colitis; 2015 May; 9(5):382-9. PubMed ID: 25740813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease.
    Lobatón T; Ferrante M; Rutgeerts P; Ballet V; Van Assche G; Vermeire S
    Aliment Pharmacol Ther; 2015 Aug; 42(4):441-51. PubMed ID: 26104047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab.
    Harrington JE; Hamilton RE; Ganley-Leal L; Farraye FA; Wasan SK
    Crohns Colitis 360; 2020 Oct; 2(4):otaa082. PubMed ID: 36777751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ideal vaccination strategy in inflammatory bowel disease].
    Lee CK
    Korean J Gastroenterol; 2015 Mar; 65(3):159-64. PubMed ID: 25797379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease.
    Gisbert JP; Villagrasa JR; Rodríguez-Nogueiras A; Chaparro M
    Am J Gastroenterol; 2012 Oct; 107(10):1460-6. PubMed ID: 23034605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive drugs impairs antibody response of the polysaccharide and conjugated pneumococcal vaccines in patients with Crohn's disease.
    Kantsø B; Halkjær SI; Thomsen OØ; Belard E; Gottschalck IB; Jørgensen CS; Krogfelt KA; Slotved HC; Ingels H; Petersen AM
    Vaccine; 2015 Oct; 33(41):5464-5469. PubMed ID: 26275480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to a predefined vaccination program in patients with inflammatory bowel disease.
    Ruiz-Cuesta P; González-Alayón C; Jurado-García J; Iglesias-Flores EM; Barranco-Quintana JL; García-García L; Salgueiro-Rodríguez IM; Benitez-Cantero JM; García-Sánchez V
    Gastroenterol Hepatol; 2016; 39(6):385-92. PubMed ID: 26601992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.